Allergan has been hit with hefty fines over the past several months. This article outlines Allergan’s alleged wrongdoing, and the settlement amount agreed to by the government and Allergan.
The Life Science industry is no stranger to sales representatives as whistleblowers. Nor is the industry a stranger to claims of “sham” educational programs as disguised kickbacks to prescribers. Allergan (formerly Forest Laboratories) early in 2017 became the first in a long line of companies to settle claims with both the U.S. Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) – albeit on different issues.